Proteome Sciences plc (AIM:PRM)
London · Delayed Price · Currency is GBP · Price in GBX 1.855
+0.255 (15.94%)
May 28, 2026, 2:01 PM GMT
Proteome Sciences Market Cap
Proteome Sciences has a market cap or net worth of 5.61 million as of May 28, 2026. Its market cap has decreased by -41.69% in one year.
Market Cap
5.61M
Enterprise Value
20.60M
Revenue
3.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.86
Market Cap Chart
Since March 1, 1999, Proteome Sciences's market cap has decreased from 11.17M to 5.61M, a decrease of -49.77%. That is a compound annual growth rate of -2.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 5.61M | -23.96% |
| Dec 31, 2025 | 7.38M | -26.47% |
| Dec 31, 2024 | 10.04M | -24.94% |
| Dec 29, 2023 | 13.37M | 29.43% |
| Dec 30, 2022 | 10.33M | -31.71% |
| Dec 31, 2021 | 15.13M | 32.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 216.52B |
| GSK plc | 76.85B |
| Haleon | 30.29B |
| Smith & Nephew | 9.68B |
| Verici Dx | 6.43M |
| OptiBiotix Health | 5.94M |
| CRISM Therapeutics | 5.43M |
| Thalia Therapeutics | 5.41M |